BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16544878)

  • 1. Immunoaffinity chromatographic and immunoprecipitation methods combined with mass spectrometry for characterization of circulating transthyretin.
    Heegaard NH; Hansen MZ; Sen JW; Christiansen M; Westermark P
    J Sep Sci; 2006 Feb; 29(3):371-7. PubMed ID: 16544878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of post-translational modifications in human serum transthyretin associated with familial amyloidotic polyneuropathy by targeted LC-MS and intact protein MS.
    Vilà-Rico M; Colomé-Calls N; Martín-Castel L; Gay M; Azorín S; Vilaseca M; Planas A; Canals F
    J Proteomics; 2015 Sep; 127(Pt B):234-46. PubMed ID: 25910794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum transthyretin monomer in patients with familial amyloid polyneuropathy.
    Sekijima Y; Tokuda T; Kametani F; Tanaka K; Maruyama K; Ikeda S
    Amyloid; 2001 Dec; 8(4):257-62. PubMed ID: 11791618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A chemometric approach for characterization of serum transthyretin in familial amyloidotic polyneuropathy type I (FAP-I) by electrospray ionization-ion mobility mass spectrometry.
    Pont L; Sanz-Nebot V; Vilaseca M; Jaumot J; Tauler R; Benavente F
    Talanta; 2018 May; 181():87-94. PubMed ID: 29426546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application to transthyretin analysis].
    Ueda M; Ando Y
    Rinsho Byori; 2006 Jun; 54(6):601-8. PubMed ID: 16872010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of transthyretin variants in familial transthyretin amyloidosis by mass spectrometric peptide mapping and DNA sequence analysis.
    Lim A; Prokaeva T; McComb ME; O'Connor PB; Théberge R; Connors LH; Skinner M; Costello CE
    Anal Chem; 2002 Feb; 74(4):741-51. PubMed ID: 11866053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of S-sulfonation and S-thiolation of a novel transthyretin Phe33Cys variant from a patient diagnosed with familial transthyretin amyloidosis.
    Lim A; Prokaeva T; McComb ME; Connors LH; Skinner M; Costello CE
    Protein Sci; 2003 Aug; 12(8):1775-85. PubMed ID: 12876326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of transthyretin in human serum by capillary zone electrophoresis electrospray ionization time-of-flight mass spectrometry. Application to familial amyloidotic polyneuropathy type I.
    Pont L; Benavente F; Barbosa J; Sanz-Nebot V
    Electrophoresis; 2015 Jun; 36(11-12):1265-73. PubMed ID: 25820240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid detection of wild-type and mutated transthyretins.
    Tasaki M; Ueda M; Obayashi K; Motokawa H; Kinoshita Y; Suenaga G; Yanagisawa A; Toyoshima R; Misumi Y; Masuda T; Yamashita T; Ando Y
    Ann Clin Biochem; 2016 Jul; 53(Pt 4):508-10. PubMed ID: 26342004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New simple and quick method to analyze serum variant transthyretins: direct MALDI method for the screening of hereditary transthyretin amyloidosis.
    Nomura T; Ueda M; Tasaki M; Misumi Y; Masuda T; Inoue Y; Tsuda Y; Okada M; Okazaki T; Kanenawa K; Isoguchi A; Nakamura M; Obayashi K; Shinriki S; Matsui H; Yamashita T; Ando Y
    Orphanet J Rare Dis; 2019 May; 14(1):116. PubMed ID: 31133063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of serum transthyretin by electrospray ionisation-ion mobility mass spectrometry: Application to familial amyloidotic polyneuropathy type I (FAP-I).
    Pont L; Benavente F; Vilaseca M; Giménez E; Sanz-Nebot V
    Talanta; 2015 Nov; 144():1216-24. PubMed ID: 26452950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On-Line Immunoaffinity Solid-Phase Extraction Capillary Electrophoresis-Mass Spectrometry for the Analysis of Serum Transthyretin.
    Pero-Gascon R; Pont L; Sanz-Nebot V; Benavente F
    Methods Mol Biol; 2019; 1972():57-76. PubMed ID: 30847784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new diagnostic procedure to detect unknown transthyretin (TTR) mutations in familial amyloidotic polyneuropathy (FAP).
    Yamashita T; Ando Y; Bernt Suhr O; Nakamura M; Sakashita N; Ohlsson PI; Terazaki H; Obayashi K; Uchino M; Ando M
    J Neurol Sci; 2000 Feb; 173(2):154-9. PubMed ID: 10675660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SELDI-TOF mass spectrometry evaluation of variant transthyretins for diagnosis and pathogenesis of familial amyloidotic polyneuropathy.
    Ueda M; Misumi Y; Mizuguchi M; Nakamura M; Yamashita T; Sekijima Y; Ota K; Shinriki S; Jono H; Ikeda S; Suhr OB; Ando Y
    Clin Chem; 2009 Jun; 55(6):1223-7. PubMed ID: 19372189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation into thiol conjugation of transthyretin in hereditary transthyretin amyloidosis.
    Suhr OB; Ando Y; Ohlsson PI; Olofsson A; Andersson K; Lundgren E; Ando M; Holmgren G
    Eur J Clin Invest; 1998 Aug; 28(8):687-92. PubMed ID: 9767365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of different forms of variant transthyretin (Met30) in cerebrospinal fluid.
    Ando Y; Suhr O; Yamashita T; Ohlsson PI; Holmgren G; Obayashi K; Terazaki H; Mambule C; Uchino M; Ando M
    Neurosci Lett; 1997 Dec; 238(3):123-6. PubMed ID: 9464635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of serum transthyretin by on-line immunoaffinity solid-phase extraction capillary electrophoresis mass spectrometry using magnetic beads.
    Peró-Gascón R; Pont L; Benavente F; Barbosa J; Sanz-Nebot V
    Electrophoresis; 2016 May; 37(9):1220-31. PubMed ID: 26842820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid: a prescription for central nervous system amyloidosis?
    Hammarström P; Sekijima Y; White JT; Wiseman RL; Lim A; Costello CE; Altland K; Garzuly F; Budka H; Kelly JW
    Biochemistry; 2003 Jun; 42(22):6656-63. PubMed ID: 12779320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detailed structural analysis of amyloidogenic wild-type transthyretin using a novel purification strategy and mass spectrometry.
    Kingsbury JS; Théberge R; Karbassi JA; Lim A; Costello CE; Connors LH
    Anal Chem; 2007 Mar; 79(5):1990-8. PubMed ID: 17261023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Proteomic Variability Associated with Clinical Phenotype in Familial Transthyretin Amyloidosis (ATTRm).
    Chan GG; Koch CM; Connors LH
    J Proteome Res; 2017 Nov; 16(11):4104-4112. PubMed ID: 28922609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.